NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Stock Market Sees Significant Selloff on Thursday

The Indian stock market experienced a sharp decline in morning trade on Thursday, April 30, with the benchmarks, the Sensex and the Nifty 50, plummeting by more than 1%. The 30-share pack Sensex plummeted by 1,150 points, or 1.5%, to an intraday low of 76,349, while the Nifty 50 dropped by over 350 points, or 1.6%, to a day low of 23,801.

As a result of this selloff, investors lost almost ₹9 lakh crore as the market capitalization of BSE-listed firms fell to ₹460 lakh crore from ₹469 lakh crore in the previous session. The rupee also fell past 95 per US dollar to a record low, dragged down by rising oil costs and the US Federal Reserve's hawkish stance. Brent crude rose to a four-year high of $126 per barrel after Axios reported that the US military plans to inform President Donald Trump on fresh options against Iran.

On Wednesday, Trump met with oil companies to discuss how to offset the impact of a possible months-long blockade of Iran's ports, raising concerns about long-term supply disruptions. Higher oil prices pose inflation risks for India, the world's third-largest crude importer, as well as endangering economic growth and business profits.

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Market Outlook

Nagaraj Shetti, Senior Technical Research Analyst of HDFC Securities, notes that the Nifty 50 slipped into weakness on the backdrop of looming West-Asia crises and rise in International Crude Oil prices on Thursday. After opening on a downside gap of 170 points, the market slipped into further weakness soon after the opening. The recovery attempt of early part has failed and Nifty 50 is currently placed at the lows.

StockCurrent PriceTarget PriceStoplossTimeframe
Time Technoplast₹190.50₹203₹1841 week
Gujarat Ambuja Exports₹154.50₹164₹1501 week

Based on technical analysis, HDFC Securities recommends buying Time Technoplast at ₹190.50 with a target price of ₹203 and a stoploss of ₹184, with a timeframe of 1 week. Time Technoplast share price has bounced back on Thursday, forming a higher bottom at ₹182 levels and attempting to regain the hurdle of 200-day EMA. The volume pattern and RSI also show positive indications.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Similarly, HDFC Securities recommends buying Gujarat Ambuja Exports at ₹154.50 with a target price of ₹164 and a stoploss of ₹150, with a timeframe of 1 week. Gujarat Ambuja Exports share price has been moving in a broader high-low range of ₹145-160 levels in the last few weeks, with the supports of 10/20-day EMA held during the up move. Bullish chart patterns like higher tops and bottoms are also observed on the daily timeframe chart, with daily 14-period RSI showing bullish indications.

Investor Takeaway

Investors should be cautious and consider diversifying their portfolios due to the current market volatility.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.